Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers
Authors
Keywords
Imatinib, Trastuzumab, Left Ventricular Ejection Fraction, Acute Lymphoblastic Leukemia, Sorafenib
Journal
PEDIATRIC DRUGS
Volume 16, Issue 5, Pages 373-389
Publisher
Springer Nature
Online
2014-08-18
DOI
10.1007/s40272-014-0085-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure
- (2014) F. Lennie Wong et al. ANNALS OF INTERNAL MEDICINE
- Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia
- (2013) Steven E. Lipshultz et al. CANCER
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
- (2013) Steven E. Lipshultz et al. CIRCULATION
- A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults’ trials
- (2013) Xavier Paoletti et al. EUROPEAN JOURNAL OF CANCER
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
- (2013) Kashif Kalam et al. EUROPEAN JOURNAL OF CANCER
- An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies
- (2013) Patricia Zerra et al. EXPERT OPINION ON PHARMACOTHERAPY
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
- (2013) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?
- (2013) A Tefferi LEUKEMIA
- Treatment-related cardiotoxicity in survivors of childhood cancer
- (2013) Steven E. Lipshultz et al. Nature Reviews Clinical Oncology
- Cancer-Drug Discovery and Cardiovascular Surveillance
- (2013) John D. Groarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dietary Quality, Caloric Intake, and Adiposity of Childhood Cancer Survivors and Their Siblings: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
- (2013) David C. Landy et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Ethnic group differences in cardiometabolic disease risk factors independent of body mass index among American youth
- (2013) Sarah E. Messiah et al. Obesity
- Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: A north American perspective
- (2013) Etan Orgel et al. PEDIATRIC BLOOD & CANCER
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients
- (2013) Daniela Cardinale et al. SEMINARS IN ONCOLOGY
- Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
- (2013) Steven M. Bair et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
- (2013) Mariele Dessì et al. SpringerPlus
- Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: An analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
- (2012) David C. Landy et al. AMERICAN HEART JOURNAL
- The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review
- (2012) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report
- (2012) B. C. Widemann et al. CLINICAL CANCER RESEARCH
- Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks
- (2012) Mark P. Little et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia
- (2012) Antonio Ruggiero et al. International Journal of Clinical Oncology
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic Therapy
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Left Ventricular Longitudinal Strain with Anthracycline Chemotherapy in Adolescents Precede Subsequent Decreased Left Ventricular Ejection Fraction
- (2012) Joseph T. Poterucha et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2012) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
- (2012) Eva van Rooij et al. NATURE REVIEWS DRUG DISCOVERY
- Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: Analysis of a national cohort of patients in the pediatric health information systems database
- (2012) Dana M. Walker et al. PEDIATRIC BLOOD & CANCER
- Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group
- (2012) Cameron K. Tebbi et al. PEDIATRIC BLOOD & CANCER
- Exercise capacity in long-term survivors of pediatric cancer: An analysis from the cardiac risk factors in childhood cancer survivors study
- (2012) Angela M. Miller et al. PEDIATRIC BLOOD & CANCER
- Cranial Irradiation as an Additional Risk Factor for Anthracycline Cardiotoxicity in Childhood Cancer Survivors: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
- (2012) David C. Landy et al. PEDIATRIC CARDIOLOGY
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
- (2012) S. E. Lipshultz et al. PEDIATRICS
- Left Ventricular Function Assessed by Two-Dimensional Speckle Tracking Echocardiography in Long-Term Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy With or Without Anthracycline Therapy
- (2011) Huey-Ru Tsai et al. AMERICAN JOURNAL OF CARDIOLOGY
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
- (2011) Heloisa Sawaya et al. AMERICAN JOURNAL OF CARDIOLOGY
- Are we there yet? Bevacizumab therapy for retinopathy of prematurity
- (2011) Brian A Darlow et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- Circulating MicroRNAs
- (2011) Stephan Fichtlscherer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review
- (2011) Denise M. Oliansky et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
- (2011) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Left Ventricular Twisting and Untwisting Motion in Childhood Cancer Survivors
- (2011) Yiu-fai Cheung et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Let-7g is involved in doxorubicin induced myocardial injury
- (2011) Jun Fu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
- (2011) Lynda M. Vrooman et al. EUROPEAN JOURNAL OF CANCER
- Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy
- (2011) P. W. Stoodley et al. European Journal of Echocardiography
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia
- (2011) Hiroto Inaba et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- A molecular MRI probe to detect treatment of cardiac apoptosis in vivo
- (2011) Rajesh Dash et al. MAGNETIC RESONANCE IN MEDICINE
- Treatment of high-grade glioma in children and adolescents
- (2011) T. J. MacDonald et al. NEURO-ONCOLOGY
- The Avastin Story
- (2011) Mikkael A. Sekeres NEW ENGLAND JOURNAL OF MEDICINE
- Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
- (2011) Barry H. Trachtenberg et al. PEDIATRIC CARDIOLOGY
- Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy
- (2011) H. Motoki et al. European Heart Journal-Cardiovascular Imaging
- Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
- (2011) M. Suttorp et al. Hematology-American Society of Hematology Education Program
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Characteristics and Determinants of Adiposity in Pediatric Cancer Survivors
- (2010) T. L. Miller et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
- (2010) Takahiro Horie et al. CARDIOVASCULAR RESEARCH
- Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation
- (2010) L. Xie et al. CARDIOVASCULAR RESEARCH
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
- (2010) Dirk J. A. Lok et al. Clinical Research in Cardiology
- Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
- (2010) James A. de Lemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2010) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
- (2010) Markhaba Tukenova et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- Diabetes Mellitus in Long-term Survivors of Childhood Cancer
- (2009) Lillian R. Meacham et al. ARCHIVES OF INTERNAL MEDICINE
- A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
- (2009) C. L. Schwartz et al. BLOOD
- Predictors of inactive lifestyle among adult survivors of childhood cancer
- (2009) Kirsten K Ness et al. CANCER
- Association of Cystatin C With Left Ventricular Structure and Function
- (2009) Parag C. Patel et al. Circulation-Heart Failure
- Galectin-3: a novel mediator of heart failure development and progression
- (2009) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Newer Biomarkers in Heart Failure
- (2009) Sachin Gupta et al. Heart Failure Clinics
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- A Phase I Study of the Safety and Pharmacokinetics of the Combination of Pertuzumab (rhuMab 2C4) and Capecitabine in Patients with Advanced Solid Tumors
- (2008) J. Albanell et al. CLINICAL CANCER RESEARCH
- Evaluation of the Left Ventricular Function with Tissue Tracking and Tissue Doppler Echocardiography in Pediatric Malignancy Survivors after Anthracycline Therapy
- (2008) Cemşit Karakurt et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Smoking Cessation Outcomes Among Childhood Cancer Survivors in the Partnership for Health Study
- (2008) Karen M. Emmons et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Martee L. Hensley et al. JOURNAL OF CLINICAL ONCOLOGY
- Strain Rate Imaging Detects Early Cardiac Effects of Pegylated Liposomal Doxorubicin as Adjuvant Therapy in Elderly Patients with Breast Cancer
- (2008) Ruxandra Jurcut et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
- (2008) A. C. Mertens et al. JNCI-Journal of the National Cancer Institute
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers in Heart Failure
- (2008) Eugene Braunwald NEW ENGLAND JOURNAL OF MEDICINE
- Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group
- (2008) S. M. Shankar et al. PEDIATRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More